Skip to content

OSTEOPEDIA

Active
Private limited companyfounded 20241 yr activeRue du Millénaire(W-B) 11, 1440 Braine-le-Château, BelgiumKBO/BCE: BE 1016.349.073
Summary

OSTEOPEDIA has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €8,763 and a net result of €8,591. Its solvency ranks better than 61% of 3521 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability100▲+100
Solvency87▲+56
Growth78
Track record82
Bankruptcy probability, 12 months
0.5% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €500 at 30 days acceptable
Liquidity ample (current ratio 2.44; short-term debt: 38.2% and cash: 70.6% of total assets), and 38.2% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 74
Relative position
BE, all sectors
reference
Other professional, scientific and technical activities (NACE 74)
about 48% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
61.8%
Return on assets
60.6%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
4 d early
2024
36 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 20 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 38% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 19 November 2024, OSTEOPEDIA was incorporated as a Private limited company.1 The company has filed 2 sets of annual accounts, the latest for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€8,763▲ 5,008%
2024 · €172
Total assets
€14,187▲ 375%
2024 · €2,985
Net result
€8,591
2024 · -€2,828
Working capital
€7,808▲ 925%
2024 · €762
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 74, Other professional, scientific and technical activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20242025
Operating result-€2,806-€10,755
Net result-€2,828below the sector's middle half-€8,591within the sector's middle half
Equity€172below the sector's middle half-€8,763below the sector's middle half▲ 5,008%
Total assets€2,985below the sector's middle half-€14,187below the sector's middle half▲ 375%
Debt€2,814-€5,424▲ 92.8%
Working capital€762within the sector's middle half-€7,808within the sector's middle half▲ 925%
Solvency61.8%within the sector's middle half
Current ratio2.44within the sector's middle half
Return on assets (ROA)60.6%above the sector's middle half
above within below the middle half (P25 to P75) of NACE 74, Other professional, scientific and technical activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
-€5,000€0€5,000€10,000Operating result 2024: -€2,806-€2,806Net result 2024: -€2,828-€2,828Operating result 2025: €10,755€10,755Net result 2025: €8,591€8,59120242025-€5,000€0€5,000€10,000Operating result 2024: -€2,806-€2,810Net result 2024: -€2,828-€2,830Operating result 2025: €10,755€10,800Net result 2025: €8,591€8,59020242025
The operating result returns to profit in 2025: €10,755 after a loss of €2,806 in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €14,187
Fixed assets €955 ▼ 20.1%
Current assets €13,232 ▲ 639%
Equity and liabilities €14,187
Equity €8,763 ▲ 5,008%
Debt €5,424 ▲ 92.8%
Debt's share of the balance-sheet total falls from 94.3% to 38.2%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€10,995▲
2024 · -€2,801
Cash flow
€8,831▲
2024 · -€2,823
Debt to equity
0.62
ROE
98.0%
Interest coverage
49.93▲
2024 · -127.04
Debt ≤ 1 year
€5,424▲
2024 · €1,029
Income taxes
€1,966
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 11,280 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 97% are still going.

  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
2.6% stopped otherwise
97% still going

For this company itself Checked computes a bankruptcy probability of 0.5% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 11,280 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 34 lines
Balance sheet Code20242025
Assets
Total assets20/58€2,985€14,187▲
Fixed assets21/28€1,195€955▼
Intangible fixed assets21€1,195€955▼
Current assets29/58€1,790€13,232▲
Amounts receivable within one year40/41€330€2,967▲
Other amounts receivable41€330€2,967▲
Cash at bank and in hand54/58€1,460€10,015▲
Deferred charges and accrued income490/1-€250
Equity and liabilities
Total equity and liabilities10/49€2,985€14,187▲
Equity10/15€172€8,763▲
Contributions10/11€3,000€3,000=
Profit (loss) carried forward14-€2,828€5,763▲
Amounts payable17/49€2,814€5,424▲
Amounts payable within one year42/48€1,029€5,424▲
Trade debts44€1,029€400▼
Suppliers440/4€1,029€400▼
Advances received on contracts in progress46-€2,250
Taxes, remuneration and social security45-€2,774
Taxes450/3-€2,774
Accrued charges and deferred income492/3€1,785€0▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5€240▲
Other operating charges640/8€537€400▼
Gross operating margin9900-€2,264€11,395▲
Operating profit (loss)9901-€2,806€10,755▲
Financial income75/76B-€23
Recurring financial income75-€23
Financial charges65/66B€22€220▲
Recurring financial charges65€22€220▲
Profit (loss) for the period before taxes9903-€2,828€10,558▲
Income taxes67/77-€1,966
Profit (loss) for the period9904-€2,828€8,591▲
Profit (loss) for the period to be appropriated9905-€2,828€8,591▲
Appropriation of the result
Profit (loss) to be appropriated9906-€2,828€5,763▲
Profit (loss) brought forward from the previous period14P--€2,828

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5€240▲ 4,498%
Other operating charges640/8€537€400▼ 25.6%
Gross operating margin9900-€2,264€11,395▲ 603%
Operating profit (loss)9901-€2,806€10,755▲ 483%
Financial income75/76B-€23-
Recurring financial income75-€23-
Financial charges65/66B€22€220▲ 899%
Recurring financial charges65€22€220▲ 899%
Profit (loss) for the period before taxes9903-€2,828€10,558▲ 473%
Income taxes67/77-€1,966-
Profit (loss) for the period9904-€2,828€8,591▲ 404%
Profit (loss) for the period to be appropriated9905-€2,828€8,591▲ 404%
Line20242025Change
Assets
Total assets20/58€2,985€14,187▲ 375%
Fixed assets21/28€1,195€955▼ 20.1%
Intangible fixed assets21€1,195€955▼ 20.1%
Current assets29/58€1,790€13,232▲ 639%
Amounts receivable within one year40/41€330€2,967▲ 798%
Other amounts receivable41€330€2,967▲ 798%
Cash at bank and in hand54/58€1,460€10,015▲ 586%
Deferred charges and accrued income490/1-€250-
Equity and liabilities
Total equity and liabilities10/49€2,985€14,187▲ 375%
Equity10/15€172€8,763▲ 5,008%
Contributions10/11€3,000€3,000=
Profit (loss) carried forward14-€2,828€5,763▲ 304%
Amounts payable17/49€2,814€5,424▲ 92.8%
Amounts payable within one year42/48€1,029€5,424▲ 427%
Trade debts44€1,029€400▼ 61.1%
Suppliers440/4€1,029€400▼ 61.1%
Advances received on contracts in progress46-€2,250-
Taxes, remuneration and social security45-€2,774-
Taxes450/3-€2,774-
Accrued charges and deferred income492/3€1,785€0▼ 100%
Line20242025Change
Profit (loss) for the period9904-€2,828€8,591▲ 404%
+ Depreciation and write-downs630€5€240▲ 4,498%
Operating cash flow (approximation)-€2,823€8,831▲ 413%
Investment in fixed assets (approximation)-€0-
Change in cash-€8,555-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
27-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Back to profitnet €8,591
Net result €8,591 after one loss-making year.
25-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Braine-le-Château · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
522 m²
Building footprint
98 m²
Volume, LiDAR
773 m³
Parcel 25111B0004/00R015, Wallonia · tallest building 9.9 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
OSTEOPEDIA
Rue du Millénaire(W-B) 11, 1440 Braine-le-ChâteauWholesale of pharmaceutical and medical goods
since 20242.366.955.693
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
25111B0004/00R015 Wallonia 522 m² 1 · 98 m² 9.9 m · 3 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 4,560 companies in sector 74999 we hold annual accounts for 1,935. 941 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded19-11-2024
Fiscal year end31-12
Activities, NACEBEL 2025
74999Other professional, scientific and technical activities
46460Wholesale of pharmaceutical and medical goods
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
82300Organisation of conventions and trade shows
85592Vocational training
85599Other education
E-invoicing
Reachable via Peppol
Peppol ID 0208:1016349073
Also 9925:BE1016349073
Registered 03-02-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.